Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CH, MTA, and Formocresol for Direct Pulp Capping in Primary Molars
NCT05222243Phase 4Completed
- Sponsor
- Mansoura University
- Start
- Jan 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of mineral trioxide aggregate, formocresol in reversible pulpitis, sponsored by Mansoura University. Started Jan 2019; status: completed.
02
Drugs
mineral trioxide aggregateformocresol
03
Conditions
reversible pulpitis
Beyond the preview
Go deeper on NCT05222243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05222243.